JP2019535807A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535807A5
JP2019535807A5 JP2019541679A JP2019541679A JP2019535807A5 JP 2019535807 A5 JP2019535807 A5 JP 2019535807A5 JP 2019541679 A JP2019541679 A JP 2019541679A JP 2019541679 A JP2019541679 A JP 2019541679A JP 2019535807 A5 JP2019535807 A5 JP 2019535807A5
Authority
JP
Japan
Prior art keywords
nitrogen
oxygen
sulfur
independently
heteroatoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019541679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019535807A (ja
JP7082130B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/056555 external-priority patent/WO2018071794A1/en
Publication of JP2019535807A publication Critical patent/JP2019535807A/ja
Publication of JP2019535807A5 publication Critical patent/JP2019535807A5/ja
Priority to JP2022000195A priority Critical patent/JP7498200B2/ja
Application granted granted Critical
Publication of JP7082130B2 publication Critical patent/JP7082130B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019541679A 2016-10-14 2017-10-13 Ｔｙｋ２阻害剤およびその使用 Active JP7082130B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022000195A JP7498200B2 (ja) 2016-10-14 2022-01-04 Ｔｙｋ２阻害剤およびその使用

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US201662408464P 2016-10-14 2016-10-14
US62/408,464 2016-10-14
US201662410334P 2016-10-19 2016-10-19
US201662410327P 2016-10-19 2016-10-19
US62/410,334 2016-10-19
US62/410,327 2016-10-19
US201662413829P 2016-10-27 2016-10-27
US62/413,829 2016-10-27
US201662415920P 2016-11-01 2016-11-01
US62/415,920 2016-11-01
US201762468749P 2017-03-08 2017-03-08
US201762468767P 2017-03-08 2017-03-08
US201762468807P 2017-03-08 2017-03-08
US62/468,767 2017-03-08
US62/468,807 2017-03-08
US62/468,749 2017-03-08
US201762546278P 2017-08-16 2017-08-16
US62/546,278 2017-08-16
PCT/US2017/056555 WO2018071794A1 (en) 2016-10-14 2017-10-13 Tyk2 inhibitors and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022000195A Division JP7498200B2 (ja) 2016-10-14 2022-01-04 Ｔｙｋ２阻害剤およびその使用

Publications (3)

Publication Number Publication Date
JP2019535807A JP2019535807A (ja) 2019-12-12
JP2019535807A5 true JP2019535807A5 (enExample) 2020-11-19
JP7082130B2 JP7082130B2 (ja) 2022-06-07

Family

ID=61906011

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019541679A Active JP7082130B2 (ja) 2016-10-14 2017-10-13 Ｔｙｋ２阻害剤およびその使用
JP2022000195A Active JP7498200B2 (ja) 2016-10-14 2022-01-04 Ｔｙｋ２阻害剤およびその使用
JP2023091142A Withdrawn JP2023106606A (ja) 2016-10-14 2023-06-01 Ｔｙｋ２阻害剤およびその使用
JP2025202716A Pending JP2026035684A (ja) 2016-10-14 2025-11-25 Ｔｙｋ２阻害剤およびその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022000195A Active JP7498200B2 (ja) 2016-10-14 2022-01-04 Ｔｙｋ２阻害剤およびその使用
JP2023091142A Withdrawn JP2023106606A (ja) 2016-10-14 2023-06-01 Ｔｙｋ２阻害剤およびその使用
JP2025202716A Pending JP2026035684A (ja) 2016-10-14 2025-11-25 Ｔｙｋ２阻害剤およびその使用

Country Status (10)

Country Link
US (4) US10323036B2 (enExample)
EP (2) EP3526222B1 (enExample)
JP (4) JP7082130B2 (enExample)
CN (2) CN115448916B (enExample)
AU (3) AU2017342464B2 (enExample)
CA (1) CA3039202A1 (enExample)
ES (1) ES2930198T3 (enExample)
IL (2) IL315777A (enExample)
TW (2) TWI763722B (enExample)
WO (1) WO2018071794A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI788655B (zh) 2015-02-27 2023-01-01 美商林伯士拉克許米公司 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
TWI707852B (zh) 2015-09-02 2020-10-21 美商林伯士拉克許米公司 Tyk2 抑制劑及其用途
US10323036B2 (en) 2016-10-14 2019-06-18 Nimbus Lakshmi, Inc. TYK2 inhibitors and uses thereof
GB201617871D0 (en) * 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds
EP3528816A4 (en) * 2016-10-21 2020-04-08 Nimbus Lakshmi, Inc. TYK2 INHIBITORS AND USES THEREOF
TW202515876A (zh) 2017-03-08 2025-04-16 日商武田藥品工業股份有限公司 Tyk2抑制劑及其用途
SI3658557T1 (sl) 2017-07-28 2024-10-30 Takeda Pharmaceutical Company Limited Zaviralci TYK2 in njihova uporaba
AR117398A1 (es) 2018-03-12 2021-08-04 Abbvie Inc Inhibidores de la señalización mediada por tirosina cinasa 2
CN112839648B (zh) * 2018-06-07 2025-04-04 达萨玛治疗公司 Sarm1抑制剂
WO2020051424A1 (en) 2018-09-07 2020-03-12 Pic Therapeutics Eif4e inhibitors and uses thereof
CN113271940A (zh) * 2018-10-15 2021-08-17 林伯士拉克许米公司 Tyk2抑制剂和其用途
CA3120866A1 (en) * 2018-11-30 2020-06-04 Nimbus Lakshmi, Inc. Tyk2 inhibitors and uses thereof
CN113348021B (zh) * 2019-01-23 2025-07-11 武田药品工业株式会社 Tyk2抑制剂和其用途
SG11202108162SA (en) * 2019-01-30 2021-08-30 Bristol Myers Squibb Co Amide-disubstituted pyridine or pyridazine compounds
SG11202112043PA (en) 2019-04-30 2021-11-29 Celgene Corp Combination therapies comprising apremilast and tyk2 inhibitors
CA3147573A1 (en) 2019-07-17 2021-01-21 2692372 Ontario, Inc. Benzenesulfonamide derivatives and uses thereof
KR20220059519A (ko) * 2019-09-11 2022-05-10 화이자 인코포레이티드 키나제 억제제에 의한 한선염의 치료
WO2021170046A1 (en) 2020-02-26 2021-09-02 Beigene, Ltd. Tyk-2 inhibitor
TW202146393A (zh) 2020-03-03 2021-12-16 美商皮克醫療公司 Eif4e抑制劑及其用途
WO2021237121A1 (en) * 2020-05-21 2021-11-25 Gossamer Bio Services, Inc. Substituted pyridines
KR20230042278A (ko) * 2020-06-22 2023-03-28 베이진 엘티디 Tyk-2 저해제
WO2022083560A1 (zh) * 2020-10-19 2022-04-28 南京药石科技股份有限公司 Tyk2选择性抑制剂及其用途
GB2617477A (en) 2020-11-20 2023-10-11 2692372 Ontario Inc Benzenesulfonamide derivatives and uses thereof
US20240124440A1 (en) * 2020-12-23 2024-04-18 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
AU2022222470A1 (en) 2021-02-19 2023-09-21 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
CA3208361A1 (en) 2021-02-19 2022-08-25 Anjali Pandey Tyk2 inhibitors and uses thereof
EP4294806A1 (en) 2021-02-19 2023-12-27 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
CA3213816A1 (en) 2021-03-16 2022-09-22 Anrui Biomedical Technology (Guangzhou) Co., Ltd. Amino heteroaryl compounds and compositions
JP7740849B2 (ja) * 2021-05-04 2025-09-17 シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド 含窒素複素環ピリジン化合物
CN115466289A (zh) * 2021-06-11 2022-12-13 爱科诺生物医药(香港)有限公司 具有tyk2抑制活性的化合物，包含其的药物组合物，及其应用
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
CA3229560A1 (en) 2021-08-25 2023-03-02 Christopher L. Vandeusen Eif4e inhibitors and uses thereof
US20240390369A1 (en) 2021-09-30 2024-11-28 Bristol-Myers Squibb Company Methods for determining responsiveness to tyk2 inhibitors
EP4423086A1 (en) 2021-10-25 2024-09-04 Kymera Therapeutics, Inc. Tyk2 degraders and uses thereof
TW202340203A (zh) * 2021-12-23 2023-10-16 英屬開曼群島商百濟神州有限公司 Ｔｙｋ２抑制劑的固體形式、製備方法及其用途
WO2023220046A1 (en) * 2022-05-10 2023-11-16 Biogen Ma Inc. Tyk2 inhibitors
WO2023248010A2 (en) 2022-06-23 2023-12-28 Synovo Gmbh Targeted modulators of jak3 for treatment of inflammatory and autoimmune diseases
US20240124450A1 (en) 2022-09-21 2024-04-18 Pfizer Inc. Novel SIK Inhibitors
CN115819429A (zh) * 2022-12-13 2023-03-21 成都睿智化学研究有限公司 一种5-氯-2,3-二氢呋喃[2,3-c]吡啶的合成方法
WO2024193689A1 (zh) * 2023-03-23 2024-09-26 广东东阳光药业股份有限公司 吡啶并吡咯衍生物及其在药物中的用途
WO2024211708A1 (en) * 2023-04-06 2024-10-10 Myrobalan Therapeutics, Inc. Tyk2 inhibitors for treatment of glaucoma
WO2024217523A1 (en) * 2023-04-20 2024-10-24 Myrobalan Therapeutics Nanjing Co. Ltd Selective tky2 inhibitors and uses thereof

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901228A (fr) 1943-01-16 1945-07-20 Deutsche Edelstahlwerke Ag Système d'aimant à entrefer annulaire
GB599891A (en) * 1944-11-17 1948-03-23 Gen Aniline & Film Corp 1-substituted-2,5-diketo-7-methyl-pyrimido-pyrazoles and process of preparing the same
US5516931A (en) 1982-02-01 1996-05-14 Northeastern University Release tag compounds producing ketone signal groups
US5650270A (en) 1982-02-01 1997-07-22 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4709016A (en) 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4650750A (en) 1982-02-01 1987-03-17 Giese Roger W Method of chemical analysis employing molecular release tag compounds
DE60037345T2 (de) 1999-12-10 2008-11-13 Pfizer Products Inc., Groton Pyrrolo(2,3-d)pyrimidin-Verbindungen
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
DE60217322T2 (de) 2001-04-27 2007-10-04 Zenyaku Kogyo K.K. Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
WO2003057689A1 (en) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
PT1536827E (pt) 2002-08-14 2009-03-20 Silence Therapeutics Ag Utilização de proteína cinase n beta
AU2004228668B2 (en) 2003-04-03 2011-10-27 Park Funding, Llc PI-3 kinase inhibitor prodrugs
ES2382377T3 (es) 2003-05-30 2012-06-07 Gemin X Pharmaceuticals Canada Inc. Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
EP1692153A4 (en) 2003-07-03 2007-03-21 Univ Pennsylvania INHIBITION OF EXPRESSION OF SYK-KINASE
CN1950389B (zh) * 2004-03-04 2011-01-19 橘生药品工业株式会社 含氮稠环衍生物，含该衍生物的药物组合物，和其作为药物的用途
WO2005113556A1 (en) 2004-05-13 2005-12-01 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
AU2006206458B2 (en) 2005-01-19 2012-10-25 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
PL1888550T3 (pl) 2005-05-12 2014-12-31 Abbvie Bahamas Ltd Promotory apoptozy
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
US7989622B2 (en) 2005-10-07 2011-08-02 Exelixis, Inc. Phosphatidylinositol 3-kinase inhibitors and methods of their use
JP5191391B2 (ja) 2005-11-01 2013-05-08 ターゲジェン インコーポレーティッド キナーゼのビ−アリールメタ−ピリミジン阻害剤
SG10202003901UA (en) 2005-12-13 2020-05-28 Incyte Holdings Corp Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
CN101437512A (zh) * 2006-01-27 2009-05-20 阿雷生物药品公司 葡萄糖激酶活化剂
KR20080092412A (ko) * 2006-02-06 2008-10-15 아이알엠 엘엘씨 단백질 키나제 억제제로서의 화합물 및 조성물
WO2007129161A2 (en) 2006-04-26 2007-11-15 F. Hoffmann-La Roche Ag Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor
DK2526933T3 (en) 2006-09-22 2015-05-18 Pharmacyclics Inc Inhibitors of Bruton's tyrosine kinase
PT2114900T (pt) * 2007-01-31 2019-01-17 Ym Biosciences Australia Pty Compostos à base de tiopirimidina e as suas utilizações
KR101566840B1 (ko) 2007-03-12 2015-11-06 와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 페닐 아미노 피리미딘 화합물 및 이의 용도
EA200901133A1 (ru) * 2007-03-20 2010-04-30 Смитклайн Бичем Корпорейшн Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
WO2008118802A1 (en) 2007-03-23 2008-10-02 Regents Of The University Of Minnesota Therapeutic compounds
PE20090717A1 (es) 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
GB0719644D0 (en) * 2007-10-05 2007-11-14 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
HUE029767T2 (en) 2008-03-11 2017-04-28 Incyte Holdings Corp JAK inhibitor azetidine and cyclobutane derivatives
EP2299816B1 (en) * 2008-06-18 2013-11-13 Merck Sharp & Dohme Corp. Inhibitors of janus kinases
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
UY32582A (es) * 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
MX2012015147A (es) * 2010-06-30 2013-05-01 Amgen Inc Compuestos heterociclicos y su uso como inhibidores de la actividad pi3k.
JP2014500254A (ja) * 2010-11-09 2014-01-09 セルゾーム リミティッド Ｔｙｋ２阻害剤としてのピリジン化合物およびそのアザ類似体
US9033542B2 (en) * 2010-11-16 2015-05-19 Dialight Corporation LED luminaire utilizing an extended and non-metallic enclosure
BR112013011520A2 (pt) * 2010-11-19 2019-09-24 Hoffmann La Roche pirazolo piridinas e pirazolo piridinas e seu uso como inibidores de tyk2
ES2575604T3 (es) * 2012-01-13 2016-06-29 Bristol-Myers Squibb Company Compuestos de piridilo sustituidos con tiazolilo o tiadiazolilo útiles como inhibidores cinasa
CN104169275B (zh) * 2012-01-13 2017-06-09 百时美施贵宝公司 用作激酶抑制剂的三唑取代的吡啶化合物
EP2802576B1 (en) * 2012-01-13 2018-06-27 Bristol-Myers Squibb Company Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
KR102233252B1 (ko) 2012-11-08 2021-03-26 브리스톨-마이어스 스큅 컴퍼니 ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
LT3495358T (lt) 2012-11-08 2022-05-25 Bristol-Myers Squibb Company Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
RU2671212C2 (ru) * 2013-02-02 2018-10-30 Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд Замещенный 2-аминопиридин в качестве ингибитора протеинкиназы
WO2014210354A1 (en) * 2013-06-28 2014-12-31 Genentech, Inc. Azaindazole compounds as inhibitors of t790m containing egfr mutants
WO2015038417A1 (en) * 2013-09-10 2015-03-19 Asana Biosciences, Llc Compounds for regulating fak and/or src pathways
TWI582077B (zh) * 2013-11-07 2017-05-11 必治妥美雅史谷比公司 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
WO2015073267A1 (en) * 2013-11-15 2015-05-21 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
ES2702126T3 (es) 2013-12-10 2019-02-27 Bristol Myers Squibb Co Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa
WO2015131080A1 (en) 2014-02-28 2015-09-03 Nimbus Lakshmi, Inc. Tyk2 inhibitors and uses thereof
NO2721710T3 (enExample) * 2014-08-21 2018-03-31
TWI788655B (zh) 2015-02-27 2023-01-01 美商林伯士拉克許米公司 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
EP3313840B1 (en) * 2015-06-24 2019-07-24 Bristol-Myers Squibb Company Heteroaryl substituted aminopyridine compounds
US10323036B2 (en) 2016-10-14 2019-06-18 Nimbus Lakshmi, Inc. TYK2 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2019535807A5 (enExample)
JP2022509260A5 (enExample)
JP2022502515A5 (enExample)
IL271999B2 (en) Tyk2 inhibitors and uses thereof
JP2018532706A5 (enExample)
AU2018265130B2 (en) Thienopyridines and benzothiophenes useful as IRAK4 inhibitors
HRP20200179T1 (hr) Spojevi heteroarila kao inhibitori irak i njihova uporaba
JP2010522210A5 (enExample)
JP2019532930A5 (enExample)
JP2016530297A5 (enExample)
JP6640222B2 (ja) ヘテロ環式誘導体およびその使用
RU2008130884A (ru) Гетероциклические ингибиторы янус-киназы 3
JP2009532475A5 (enExample)
JP2017536369A5 (enExample)
JP2019530699A5 (enExample)
HRP20100032T1 (hr) Tiadiazolidinoni kao inhibitori gsk-3
JP2013515729A5 (enExample)
JP2014512404A5 (enExample)
CA2510534A1 (en) Compositions useful as inhibitors of protein kinases
JP2020511438A5 (enExample)
JP2022500499A5 (enExample)
JP2016028076A5 (enExample)
JP2016540803A5 (enExample)
JP2024540292A5 (enExample)
CN102083809B (zh) 基于阻断TCR-Nck相互作用的免疫抑制物